Loading stock data…
HCWB
$0.45-0.02 (-4.07%)
Market ClosedLast close May 1
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
HCW Biologics Inc. in the Healthcare sector is trading at $0.45. The stock is currently near its 52-week low of $0.25, remaining 80.9% below its 200-day moving average. Technical signals show neutral RSI of 62 and bullish MACD crossover, explaining why HCWB maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 62) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.45
Potential Upside
5%
Whystock Fair Value$0.47
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW921...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.69M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.91
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-287.90%
Volume
Today's trading volume
455,526
Recent News
BC-Most Active Stocks
YY Group Holdings Ltd. 26,117,734 0.0511
Wall Street Set to Open Little Changed Friday Ahead of Consumer Sentiment Report
US stocks look set to open little changed in Friday's trading session ahead of consumer sentiment da
Consumer Sentiment, Oil Inventory Reports Set for Release as US Futures Little Changed in Friday's Premarket Session
US stock futures were little changed in Friday's premarket session ahead of consumer sentiment and o
HCW Biologics Second Quarter 2025 Earnings: US$0.90 loss per share (vs US$16.16 loss in 2Q 2024)
NasdaqCM:HCWB 1 Year Share Price vs Fair Value Explore HCW Biologics's Fair Values from the Community and select yours...
Insiders Re-Evaluate Their US$3.05m Stock Purchase As HCW Biologics Falls To US$6.9m
The recent 14% drop in HCW Biologics Inc.'s ( NASDAQ:HCWB ) stock could come as a blow to insiders who purchased...